News - Alpha Lifetech

Home
News

Application of High-Throughput Sequencing in Phage Display

2026-05-20 08:30

Alpha Lifetech has established a mature Antibody Discovery Platform to accelerate the high-affinity scFv, Fab, or VHH antibodies for your research projects.
CD274/PD-L1/B7-H1 Mechanism and Recombinant Protein Applications

2026-05-16 08:30

PD-L1 (CD274/B7-H1) is a key molecule in tumor immune escape. Recombinant PD-L1 protein and corresponding antibodies play a central role as tools in mechanistic studies and drug screening.
M13 Phage Display Library Construction for High-Affinity Monoclonal Antibody Discovery

2026-05-15 08:30

Alpha Lifetech provides phage display and screening services. It offers downstream services such as antibody expression, antibody humanization, antibody affinity maturation, and other services.
Literature Analysis (Science) | Breaking the Central Dogma: The Discovery of Protein-Templated DNA Synthesis

2026-05-14 08:30

This discovery overturns the Central Dogma by demonstrating that proteins can serve as direct templates for sequence-specific DNA synthesis, fundamentally redefining the flow of genetic information....
TNF alpha/TNFA/TNFSF2 Immune Signaling Pathways and Recombinant Protein Analysis

2026-05-08 08:30

Leveraging its professional recombinant protein R&D platform, Alpha Lifetech provides TNF/TNFR pathway and HIV-1 target proteins to support immunotherapy and drug discovery.

1 2 3 4 5